Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace M Lloyd

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Essays in Biochemistry|November 30, 2021
Targeted proteolytic products of τ and α-synuclein in neurodegenerationYuxing Xia, Grace M Lloyd, Benoit I Giasson
Brain Communications|October 10, 2025
Uncovering α-synuclein and tau burden in Alzheimer's and Lewy body diseasesStephan Quintin, Giavanna Paterno, Grace M Lloyd, et al.
Acta Neuropathologica Communications|May 4, 2021
Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophyEthan W Hass, Zachary A Sorrentino, Grace M Lloyd, et al.
Acta Neuropathologica Communications|August 29, 2021
Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathiesEthan W Hass, Zachary A Sorrentino, Yuxing Xia, et al.
Acta Neuropathologica Communications|June 10, 2024
A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal modelsGrace M Lloyd, Stephan Quintin, Zachary A Sorrentino, et al.
Virology Journal|March 30, 2021
Precision therapeutic targets for COVID-19Zachary A Krumm, Grace M Lloyd, Connor P Francis, et al.
Acta Neuropathologica|April 30, 2022
Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic miceGrace M Lloyd, Zachary A Sorrentino, Stephan Quintin, et al.
Molecular Neurodegeneration|September 10, 2021
Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse modelGrace M Lloyd, Jess-Karan S Dhillon, Kimberly-Marie M Gorion, et al.
The Journal of Biological Chemistry|June 12, 2023
Cellular processing of α-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114Stephan Quintin, Grace M Lloyd, Giavanna Paterno, et al.
Acta Neuropathologica Communications|July 23, 2023
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesisGrace M Lloyd, Brooke Long, Stephan Quintin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Essays in Biochemistry|November 30, 2021
Targeted proteolytic products of τ and α-synuclein in neurodegenerationYuxing Xia, Grace M Lloyd, Benoit I Giasson
Brain Communications|October 10, 2025
Uncovering α-synuclein and tau burden in Alzheimer's and Lewy body diseasesStephan Quintin, Giavanna Paterno, Grace M Lloyd, et al.
Acta Neuropathologica Communications|May 4, 2021
Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophyEthan W Hass, Zachary A Sorrentino, Grace M Lloyd, et al.
Acta Neuropathologica Communications|August 29, 2021
Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathiesEthan W Hass, Zachary A Sorrentino, Yuxing Xia, et al.
Acta Neuropathologica Communications|June 10, 2024
A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal modelsGrace M Lloyd, Stephan Quintin, Zachary A Sorrentino, et al.
Virology Journal|March 30, 2021
Precision therapeutic targets for COVID-19Zachary A Krumm, Grace M Lloyd, Connor P Francis, et al.
Acta Neuropathologica|April 30, 2022
Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic miceGrace M Lloyd, Zachary A Sorrentino, Stephan Quintin, et al.
Molecular Neurodegeneration|September 10, 2021
Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse modelGrace M Lloyd, Jess-Karan S Dhillon, Kimberly-Marie M Gorion, et al.
The Journal of Biological Chemistry|June 12, 2023
Cellular processing of α-synuclein fibrils results in distinct physiological C-terminal truncations with a major cleavage site at residue Glu 114Stephan Quintin, Grace M Lloyd, Giavanna Paterno, et al.
Acta Neuropathologica Communications|July 23, 2023
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesisGrace M Lloyd, Brooke Long, Stephan Quintin, et al.
Pageof 2